Neurodegeneración y neuroprotección
![Foto de Neurodegeneración y neuroprotección](/img/uploaded/565935984884aa0c9a1bf9f790310ff5.jpg)
![Foto de Karolinska Institute](/img/noimage_org.png)
Karolinska Institute
Estocolmo, SueciaPublicacións en colaboración con investigadores/as de Karolinska Institute (4)
2017
-
GPR55: A therapeutic target for Parkinson's disease?
Neuropharmacology, Vol. 125, pp. 319-332
2014
-
The monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model
Neurobiology of Aging, Vol. 35, Núm. 11, pp. 2603-2616
2010
-
Direct involvement of σ-1 receptors in the dopamine D1 receptor-mediated effects of cocaine
Proceedings of the National Academy of Sciences of the United States of America, Vol. 107, Núm. 43, pp. 18676-18681
2009
-
Interactions between calmodulin, adenosine A2A, and dopamine D2 receptors
Journal of Biological Chemistry, Vol. 284, Núm. 41, pp. 28058-28068